In a study that of the prognostic value of certain biomarker proteins for patients with coronary heart disease, circulating osteoglycin (mimecan), whose expression is increased in vulnerable atherosclerotic plaques, was called a promising biomarker of adverse cardiovascular events [73]. This evidence concerns the gene OGN and coronary artery disorder.